Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR.
Calcium-Binding Proteins
/ genetics
Child, Preschool
CpG Islands
DNA Methylation
Epigenesis, Genetic
Female
Genomic Imprinting
Hallux
/ abnormalities
Humans
Intellectual Disability
/ genetics
Membrane Proteins
/ genetics
Nails, Malformed
/ genetics
RNA, Long Noncoding
/ genetics
Thumb
/ abnormalities
Uniparental Disomy
Multilocus imprinting disturbance
Primary DMR
Secondary DMR
Temple syndrome
Journal
Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977
Informations de publication
Date de publication:
07 03 2019
07 03 2019
Historique:
received:
27
12
2018
accepted:
28
02
2019
entrez:
9
3
2019
pubmed:
9
3
2019
medline:
22
1
2020
Statut:
epublish
Résumé
The human chromosome 14q32.2 imprinted region harbors the primary MEG3/DLK1:IG-differentially methylated region (DMR) and secondary MEG3:TSS-DMR. The MEG3:TSS-DMR can remain unmethylated only in the presence of unmethylated MEG3/DLK1:IG-DMR in somatic tissues, but not in the placenta, because of a hierarchical regulation of the methylation pattern between the two DMRs. We performed molecular studies in a 4-year-old Japanese girl with Temple syndrome (TS14). Pyrosequencing analysis showed extremely low methylation levels of five CpGs at the MEG3:TSS-DMR and grossly normal methylation levels of four CpGs at the MEG3/DLK1:IG-DMR in leukocytes. HumanMethylation450 BeadChip confirmed marked hypomethylation of the MEG3:TSS-DMR and revealed multilocus imprinting disturbance (MLID) including mild hypomethylation of the H19/IGF2:IG-DMR and mild hypermethylation of the GNAS A/B:TSS-DMR in leukocytes. Bisulfite sequencing showed markedly hypomethylated CpGs at the MEG3:TSS-DMR and irregularly and non-differentially methylated CpGs at the MEG3/DLK1:IG-DMR in leukocytes and apparently normal methylation patterns of the two DMRs in the placenta. Maternal uniparental disomy 14 and a deletion involving this imprinted region were excluded. Such a methylation pattern of the MEG3/DLK1:IG-DMR has not been reported in patients with TS14. It may be possible that a certain degree of irregular hypomethylation at the MEG3/DLK1:IG-DMR has prevented methylation of the MEG3:TSS-DMR in somatic tissues and that a hypermethylation type MLID has occurred at the MEG3/DLK1:IG-DMR to yield the apparently normal methylation pattern in the placenta.
Sections du résumé
BACKGROUND
The human chromosome 14q32.2 imprinted region harbors the primary MEG3/DLK1:IG-differentially methylated region (DMR) and secondary MEG3:TSS-DMR. The MEG3:TSS-DMR can remain unmethylated only in the presence of unmethylated MEG3/DLK1:IG-DMR in somatic tissues, but not in the placenta, because of a hierarchical regulation of the methylation pattern between the two DMRs.
METHODS
We performed molecular studies in a 4-year-old Japanese girl with Temple syndrome (TS14).
RESULTS
Pyrosequencing analysis showed extremely low methylation levels of five CpGs at the MEG3:TSS-DMR and grossly normal methylation levels of four CpGs at the MEG3/DLK1:IG-DMR in leukocytes. HumanMethylation450 BeadChip confirmed marked hypomethylation of the MEG3:TSS-DMR and revealed multilocus imprinting disturbance (MLID) including mild hypomethylation of the H19/IGF2:IG-DMR and mild hypermethylation of the GNAS A/B:TSS-DMR in leukocytes. Bisulfite sequencing showed markedly hypomethylated CpGs at the MEG3:TSS-DMR and irregularly and non-differentially methylated CpGs at the MEG3/DLK1:IG-DMR in leukocytes and apparently normal methylation patterns of the two DMRs in the placenta. Maternal uniparental disomy 14 and a deletion involving this imprinted region were excluded.
CONCLUSIONS
Such a methylation pattern of the MEG3/DLK1:IG-DMR has not been reported in patients with TS14. It may be possible that a certain degree of irregular hypomethylation at the MEG3/DLK1:IG-DMR has prevented methylation of the MEG3:TSS-DMR in somatic tissues and that a hypermethylation type MLID has occurred at the MEG3/DLK1:IG-DMR to yield the apparently normal methylation pattern in the placenta.
Identifiants
pubmed: 30846001
doi: 10.1186/s13148-019-0640-2
pii: 10.1186/s13148-019-0640-2
pmc: PMC6407230
doi:
Substances chimiques
Calcium-Binding Proteins
0
DLK1 protein, human
0
MEG3 non-coding RNA, human
0
Membrane Proteins
0
RNA, Long Noncoding
0
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
42Références
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
PLoS Genet. 2014 Dec 11;10(12):e1004868
pubmed: 25501653
Genet Med. 2017 Apr;19(4):476-482
pubmed: 27632690
Nat Rev Endocrinol. 2017 Feb;13(2):105-124
pubmed: 27585961
J Med Genet. 2018 Jul;55(7):497-504
pubmed: 29574422
J Hum Genet. 2016 Jun;61(6):547-53
pubmed: 26911352
Hum Mutat. 2013 Apr;34(4):595-602
pubmed: 23335487
PLoS Genet. 2010 Jun 17;6(6):e1000992
pubmed: 20585555
Epigenetics. 2018;13(2):117-121
pubmed: 27911167
Eur J Hum Genet. 2012 Sep;20(9):928-32
pubmed: 22353941
J Med Genet. 2011 Jan;48(1):55-63
pubmed: 20972248
Nat Genet. 2008 Feb;40(2):237-42
pubmed: 18176563
Genet Med. 2014 Dec;16(12):903-12
pubmed: 24810686
Pediatrics. 2001 Nov;108(5):E92
pubmed: 11694676
J Pediatr. 2009 Dec;155(6):900-903.e1
pubmed: 19800077
Dev Cell. 2014 Oct 13;31(1):19-33
pubmed: 25263792
J Hum Genet. 2016 Feb;61(2):87-94
pubmed: 26377239
Eur J Hum Genet. 2015 Aug;23(8):1062-7
pubmed: 25351781
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2083-2088
pubmed: 29878129
Genet Med. 2017 Dec;19(12):1356-1366
pubmed: 28640239
Epigenomics. 2016 Jun;8(6):801-16
pubmed: 27323310
J Med Genet. 2014 Aug;51(8):495-501
pubmed: 24891339